Raras
Buscar doenças, sintomas, genes...
Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus
ORPHA:3044CID-10 · Q87.8OMIM 249599DOENÇA RARA

A síndrome de Deficiência Intelectual, Dismorfismo, Hipogonadismo e Diabetes Mellitus é uma condição que se manifesta com deficiência intelectual moderada e alterações físicas na cabeça e no rosto. Essas alterações incluem nariz largo com uma pequena fenda na lateral, olhos fundos e queixo proeminente. Além disso, a síndrome causa hipogonadismo (uma condição em que os órgãos sexuais, como ovários ou testículos, funcionam pouco, mesmo recebendo estímulo intenso do corpo) e uma aparência corporal com traços de pouco desenvolvimento sexual (como membros mais longos e menor desenvolvimento de massa muscular e pelos em algumas áreas). Diabetes tipo 1 e epilepsia também são características dessa síndrome. A síndrome foi descrita em quatro pacientes (três irmãos e uma irmã). Ela é provavelmente transmitida de forma autossômica recessiva, o que significa que a pessoa precisa herdar uma cópia do gene alterado de cada um dos pais para desenvolver a condição.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Deficiência Intelectual, Dismorfismo, Hipogonadismo e Diabetes Mellitus é uma condição que se manifesta com deficiência intelectual moderada e alterações físicas na cabeça e no rosto. Essas alterações incluem nariz largo com uma pequena fenda na lateral, olhos fundos e queixo proeminente. Além disso, a síndrome causa hipogonadismo (uma condição em que os órgãos sexuais, como ovários ou testículos, funcionam pouco, mesmo recebendo estímulo intenso do corpo) e uma aparência corporal com traços de pouco desenvolvimento sexual (como membros mais longos e menor desenvolvimento de massa muscular e pelos em algumas áreas). Diabetes tipo 1 e epilepsia também são características dessa síndrome. A síndrome foi descrita em quatro pacientes (três irmãos e uma irmã). Ela é provavelmente transmitida de forma autossômica recessiva, o que significa que a pessoa precisa herdar uma cópia do gene alterado de cada um dos pais para desenvolver a condição.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
4
pacientes catalogados
Início
Childhood
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PE, CE, DF, SP +5CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
7 sintomas
🧠
Neurológico
4 sintomas
💪
Músculos
1 sintomas
👁️
Olhos
1 sintomas
🧬
Pele e cabelo
1 sintomas
📏
Crescimento
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

90%prev.
Formato facial anormal
Muito frequente (99-80%)
90%prev.
Nível elevado de hormônio luteinizante circulante
Muito frequente (99-80%)
90%prev.
Face longa
Muito frequente (99-80%)
90%prev.
Fenda da asa do nariz
Muito frequente (99-80%)
90%prev.
Deficiência intelectual, moderada
Muito frequente (99-80%)
90%prev.
Tamanho testicular diminuído
Muito frequente (99-80%)
22sintomas
Muito frequente (16)
Frequente (3)
Ocasional (3)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 22 características clínicas mais associadas, ordenadas por frequência.

Formato facial anormalAbnormal facial shape
Muito frequente (99-80%)90%
Nível elevado de hormônio luteinizante circulanteElevated circulating luteinizing hormone level
Muito frequente (99-80%)90%
Face longaLong face
Muito frequente (99-80%)90%
Fenda da asa do narizCleft ala nasi
Muito frequente (99-80%)90%
Deficiência intelectual, moderadaIntellectual disability, moderate
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos144publicações
Pico202222 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus

Centros para Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone.

Investigative ophthalmology &amp; visual science2026 Feb 02

To determine whether topical naltrexone (NTX) treatment can decrease the elevated reactive oxygen species pathways and select proinflammatory cytokines in the rat cornea and lacrimal glands that are elevated in diabetic dry eye. Type 1 diabetic male and female Sprague-Dawley rats were rendered hyperglycemic for 6-8 weeks and then treated topically with NTX eyedrops twice daily for 15 days. Corneal epithelium and lacrimal glands were evaluated for expression of dihydroethidium, C/EBP homologous protein, and NADPH oxidase -2 (NOX-2) as well as the proinflammatory cytokines interleukin (IL) -1β, IL-6, and tumor necrosis factor alpha (TNF-α) to identify pathways targeted in the mitigation of diabetic dry eye. Type 1 diabetes resulted in dry eye and corneal surface insensitivity, accompanied by increased levels of oxidative stress and inflammation mediators in both corneal epithelium and lacrimal glands. Topical NTX treatment restored tear volume and corneal surface sensitivity, and significantly reduced expression of dihydroethidium, C/EBP homologous protein, and NOX-2, as well as proinflammatory cytokines IL-1β, IL-6, and TNF-α in male and female diabetic rats. Blockade of the opioid growth factor (OGF)-OGF receptor system with topical NTX rapidly reversed diabetic dry eye and restored corneal surface sensitivity. The mechanism involved downregulating oxidative stress and decreasing proinflammatory cytokines to levels at or below those of nondiabetic rats of the same sex. These findings support a mechanistic role for OGF receptor blockade in the reversal of diabetic dry eye.

#2

Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.

Lancet (London, England)2026 Jan 17

In patients with coronary artery disease, diabetes increases the risk of restenosis and adverse cardiovascular events after percutaneous coronary intervention (PCI). The Abluminus DES+ is a thin-strut cobalt-chromium sirolimus-eluting stent (SES) with abluminal and balloon-surface coating intended to enhance drug delivery to the vessel wall. We aimed to compare the efficacy and safety of the Abluminus DES+ SES versus the XIENCE durable-polymer everolimus-eluting stent (EES) in patients with diabetes undergoing PCI. ABILITY Diabetes Global was a multicentre, prospective, open-label, randomised controlled trial conducted at 74 sites in 16 countries. Adults (aged ≥18 years) with type 1 or type 2 diabetes undergoing PCI for at least one de novo coronary lesion due to chronic coronary syndrome or non-ST-elevation acute coronary syndrome were eligible. Patients were randomly assigned (1:1) to the Abluminus DES+ SES or the XIENCE EES. Randomisation was stratified by site using a secure web-based system with concealed allocation and randomly varying block sizes (4, 6, and 8). Operators were unmasked to allocation; staff performing clinical follow-up and the independent clinical events committee were masked. For the Abluminus DES+ SES, a balloon inflation time of at least 45 s was recommended to facilitate drug transfer; dual antiplatelet therapy was prescribed to all patients according to clinical guidelines and local practice. The primary hypothesis of the study was the non-inferiority of the Abluminus DES+ SES compared with the XIENCE EES for the two coprimary endpoints at 12 months (in the per-protocol population): ischaemia-driven target-lesion revascularisation (2·8% non-inferiority margin) and target-lesion failure (3·0% margin), defined as a composite of cardiovascular death, target-vessel myocardial infarction, or ischaemia-driven target-lesion revascularisation. Time-to-event analyses were conducted with Kaplan-Meier estimates and Cox proportional hazards models. This trial is registered with ClinicalTrials.gov (NCT04236609) and is complete. Between June 12, 2020, and Sept 9, 2022, 3032 patients were randomly assigned to the Abluminus DES+ SES (n=1514) or XIENCE EES (n=1518). 2931 (96·7%) of 3032 patients completed follow-up to death or 24-month follow-up. Median age was 68·0 years (IQR 60-74). 879 (29·0%) of 3032 patients were female and 2153 (71·0%) were male. At 12 months, in the per-protocol analysis, the Abluminus DES+ SES did not meet the criteria for non-inferiority for ischaemia-driven target-lesion revascularisation compared with XIENCE EES (67 of 1421 patients [Kaplan-Meier estimate 4·8%, 95% CI 3·9-6·2] vs 30 of 1446 [2·1%, 95% CI 1·6-3·2]; absolute risk difference 2·7%, 95% CI 1·3-4·1; pnon-inferiority=0·44) and target lesion failure (137 [9·7%, 8·4-11·5] vs 89 [6·2%, 5·3-7·8]; 3·5%, 1·5-5·5; pnon-inferiority=0·68). For both endpoints, the lower bound of the 95% CI for the absolute risk difference excluded zero. Target-vessel myocardial infarction occurred more frequently in the Abluminus DES+ SES group (73 of 1421 patients [Kaplan-Meier estimate 5·2%, 95% CI 4·1-6·5] vs 44 of 1446 patients [3·1%, 2·4-4·3]) but there were no significant differences in cardiovascular death (41 of 1421 patients [2·9%, 2·1-3·9] vs 30 of 1446 patients [2·1%, 1·5-3·0]) and all-cause death (52 of 1421 patients [3·7%, 2·8-4·8] vs 48 of 1446 patients [3·3%, 2·5-4·4]). Results were consistent at 24 months in the intention-to-treat analysis, however no significant differences were observed between the two groups in landmark analyses between 12 and 24 months. In patients with diabetes undergoing PCI, the Abluminus DES+ SES was not non-inferior to the XIENCE EES, resulting in higher rates of ischaemia-driven target-lesion revascularisation and target lesion failure at 12-month follow-up. Event rates between 12 and 24 months were similar between groups. These findings highlight the persistent challenge of optimising outcomes in patients with diabetes and underscore the need for continued innovation in stent design and adjunctive pharmacotherapy to reduce residual ischaemic risk in this population. Concept Medical.

#3

Epidemiology, Comorbidities, and Healthcare Costs of Prader-Willi Syndrome in South Korea Using the Korean National Health Insurance Service Database.

Journal of obesity &amp; metabolic syndrome2026 Mar 24

Prader-Willi syndrome (PWS) is a rare genetic disorder associated with substantial comorbidity and early mortality. However, the epidemiologic burden on Asian populations, particularly in South Korea, remains poorly understood. This study evaluates the nationwide incidence, prevalence, mortality, comorbidities, and healthcare costs of PWS in South Korea. We conducted a retrospective, population-based cohort study using the Korean National Health Insurance Database from 2005 to 2021. Among 2,553 individuals with PWS-related diagnostic codes, 458 patients were included in the study based on predefined criteria incorporating growth hormone therapy (GHT) or methylation-specific PCR testing. Epidemiologic trends, comorbidities, intensive care unit (ICU) admissions, and healthcare expenditures were analyzed. The overall birth incidence was 6.8 per 100,000 live births, with a significant increase evident after 2016. The median age at diagnosis was 1.0 years, and GHT was initiated at a median age of 2.0 years. The all-cause mortality rate was 3.5%, with pneumonia being the leading cause of death. ICU admission occurred in 25.5% of patients, often during infancy. Intellectual disability and/or developmental delay was present in 68.6% of patients, and type 2 diabetes mellitus in 15.1%. The mean cumulative healthcare cost per patient exceeded 86 million Korean won. Comorbidity prevalence and annual medical costs increased steadily over time. This is the first nationwide study to quantify the long-term epidemiological and economic burden of PWS in South Korea. Our findings underscore the need for early diagnosis, integrated care models, and policy support for this complex population.

#4

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus2026 Jan

Hijazi-Reis syndrome is a recently described, rare, X-linked neurodevelopmental disorder caused by loss-of-function variants in the TCEAL1 gene. Fewer than 15 cases have been reported to date, with key features including developmental delay, especially affecting expressive speech, intellectual disability, autistic traits, and variable systemic findings. We describe the case of a Portuguese girl with severe intellectual disability, absent speech, autistic traits, obesity, and mild dysmorphic facial features. Genetic testing identified a de novo exon 3 deletion in TCEAL1, confirming the diagnosis of Hijazi-Reis syndrome. At age 14, she developed type 2 diabetes with preserved insulin secretion and negative autoimmune markers. This first Portuguese case adds to the limited clinical descriptions of Hijazi-Reis syndrome and documents the occurrence of type 2 diabetes in an affected adolescent. As further cases are reported, consideration of metabolic aspects may support comprehensive follow-up and multidisciplinary care in affected individuals.

#5

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica2026 Jan 27

Cohen syndrome is a rare autosomal recessive disorder caused by biallelic pathogenic variants in the VPS13B gene, classically presenting with developmental delay, distinctive craniofacial features, neutropenia, truncal obesity, and progressive retinal dystrophy. Metabolic abnormalities, including insulin resistance and diabetes mellitus, have been increasingly recognized, but early-onset diabetes with diabetic ketoacidosis remains uncommon. We report a 28-year-old Chinese woman with early-onset insulin-resistant diabetes complicated by recurrent diabetic ketoacidosis and nephropathy. She presented with intellectual disability, characteristic facial dysmorphism, truncal obesity with slender limbs, neutropenia, and visual impairment. Diabetes was diagnosed at 24 years of age, with negative islet autoantibodies and preserved C-peptide levels. Whole-exome sequencing identified two novel compound heterozygous VPS13B variants, including a synonymous variant with predicted splice-disrupting effects and a nonsense variant, confirming the diagnosis of Cohen syndrome. This case expands the mutational and metabolic spectrum of Cohen syndrome and highlights the importance of considering syndromic causes and genetic testing in patients with atypical early-onset diabetes.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 144

2026

Epidemiology, Comorbidities, and Healthcare Costs of Prader-Willi Syndrome in South Korea Using the Korean National Health Insurance Service Database.

Journal of obesity &amp; metabolic syndrome
2025

[Clinical features and genetic analysis of a child with STISS syndrome due to variant of PSMD12 gene].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2026

Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone.

Investigative ophthalmology &amp; visual science
2026

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus
2026

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica
2026

Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.

Lancet (London, England)
2025

Revealing Monogenic Diabetes: Clinical and Genetic Features of Pediatric MODY Cases in Türkiye: Single Center Experience.

Pediatric diabetes
2026

Once-daily supplementation with pre-meal whey protein lowers breakfast postprandial glucose levels in women with GDM throughout the third trimester: a randomised, controlled, clinical trial.

Diabetologia
2025

ITCH Deficiency Causing Immunodeficiency and Immune Dysregulation.

Pediatrics
2025

A Complex Case of Koolen-De Vries Syndrome Associated with Hypopituitarism and Type 1 Diabetes Mellitus.

Acta medica portuguesa
2026

DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease.

Diabetologia
2025

Efficacy of an advanced hybrid closed-loop system in a patient with type 1 diabetes and intellectual disability: a case report.

Frontiers in endocrinology
2025

A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

A KDM6 A variant in a Chinese female patient with diabetes mellitus and oligomenorrhea: a case report.

Journal of medical case reports
2025

Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways.

Investigative ophthalmology &amp; visual science
2025

Natural history of patients with autosomal dominant WFS1 pathogenic variants associated with sensorineural hearing loss and optic atrophy.

medRxiv : the preprint server for health sciences
2025

Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes.

Diabetologia
2025

Comorbidities, Endocrine Medications, and Mortality in Prader-Willi Syndrome-A Swedish Register Study.

Journal of clinical medicine
2025

Systemic Diseases in Patients with Congenital Aniridia: A Report from the Homburg Registry for Congenital Aniridia.

Ophthalmology and therapy
2025

Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients.

The Journal of clinical endocrinology and metabolism
2025

Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells.

Diabetologia
2025

Kabuki syndrome associated with type 1 diabetes mellitus: report of three cases.

Archivos argentinos de pediatria
2025

New Insights Into TRMT10A Syndrome: Case Report and Literature Review.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2024

Efficacy of Radio Electric Asymmetric Conveyer (REAC) Biomodulation Treatments in Managing Chronic Pain, Edema, and Metabolic Syndrome: A Case Report.

Cureus
2024

Woodhouse-sakati syndrome with no reportable MRI findings: a case report.

BMC neurology
2024

Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.

Diabetologia
2024

Familial renal glycosuria identified in an Indian family.

BMJ case reports
2024

Discovery of a TRMT10A mutation in a case of atypical diabetes: Case report.

Diabetes &amp; metabolism
2024

Behavioral Changes in a Pediatric Patient With Sotos Syndrome: A Case Emphasizing the Importance of Coordinated Care.

Cureus
2024

Chronic Health Conditions Among Adults With Intellectual and Developmental Disabilities in a State Medicaid System.

American journal on intellectual and developmental disabilities
2025

Recurrent carotid paragangliomas in a syndromic patient with a heterozygous missense variant in DNA Methyltransferase 3 Alpha.

American journal of medical genetics. Part A
2024

Clinical Findings in a Series of Thirty Eight Patients with Williams-Beuren Syndrome.

Cytogenetic and genome research
2024

Evaluation of changes in carbonyl stress markers with treatment in male patients with bipolar disorder manic episode: A controlled study.

Journal of affective disorders
2024

Alström Syndrome: A Challenging Case Study of a Female Saudi Patient With Type 2 Diabetes Mellitus and Complete Vision Loss.

Cureus
2024

Topical naltrexone increases aquaporin 5 production in the lacrimal gland and restores tear production in diabetic rats.

Experimental biology and medicine (Maywood, N.J.)
2024

Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life.

Frontiers in endocrinology
2024

An interpretable predictive deep learning platform for pediatric metabolic diseases.

Journal of the American Medical Informatics Association : JAMIA
2024

Maternal and perinatal outcomes in twin pregnancies following assisted reproduction: a systematic review and meta-analysis involving 802 462 pregnancies.

Human reproduction update
2025

Woodhouse-Sakati syndrome: A review.

Revue neurologique
2023

A bibliometric perspective with research trends and global productivity on the modernization of andrology from the founder of modern clinical andrology Edward Martin to the present.

European review for medical and pharmacological sciences
2023

Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management.

Ewha medical journal
2024

Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study.

Drug and alcohol dependence
2025

Cognitive Function in Early Onset Type 1 Diabetes in Children.

Indian journal of pediatrics
2024

Two novel cases of biallelic SMPD4 variants with brain structural abnormalities.

Neurogenetics
2024

Woodhouse-Sakati syndrome in an Indian patient with a novel pathogenic variant.

American journal of medical genetics. Part A
2023

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

International journal of molecular sciences
2023

Megaloblastic Anemia in Bardet-Biedl Syndrome: A Rare Case Report.

Clinical medicine insights. Case reports
2023

Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review.

Frontiers in endocrinology
2023

Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history.

BMC medical genomics
2023

Identification of a Small Supernumerary Marker Chromosome in a Turner Syndrome Patient with Karyotype mos 46,X,+mar/45,X.

Genes
2023

Genetic epidemiology of Woodhouse-Sakati Syndrome in the Greater Middle East region and beyond: a systematic review.

Orphanet journal of rare diseases
2022

A new entity in the NARS2 variant: the first reported case of type 1 diabetes mellitus associated with the phenotype.

Journal of tropical pediatrics
2023

Cataract surgery outcomes in pediatric patients with systemic comorbidities.

Indian journal of ophthalmology
2023

Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.

Neuropharmacology
2022

Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis.

International immunopharmacology
2023

Prevalence of Mental, Behavioral, and Developmental Disorders Among Children and Adolescents with Diabetes, United States (2016-2019).

The Journal of pediatrics
2022

Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies.

Journal of thrombosis and haemostasis : JTH
2022

A case of familial recurrent 17q12 microdeletion syndrome presenting with severe diabetic ketoacidosis.

The Turkish journal of pediatrics
2022

Whole exome sequencing and transcript analysis discover a novel pathogenic splice site mutation in DCAF17 gene underlying Woodhouse-Sakati syndrome.

Journal of neuroendocrinology
2022

Berardinelli Seip Syndrome: A rare case report.

JPMA. The Journal of the Pakistan Medical Association
2022

Genetic Heterogeneity and Challenges in the Management of Permanent Neonatal Diabetes Mellitus: A Single-Centre Study from South India.

Indian journal of endocrinology and metabolism
2022

Diabetes mellitus and insulin resistance associated with Kabuki syndrome-A case report and literature review.

Clinical case reports
2022

Polypharmacy in a Patient With Intellectual and Developmental Disabilities.

Cureus
2022

Corrigendum: Case Report: A Chinese Family of Woodhouse-Sakati Syndrome With Diabetes Mellitus, With a Novel Biallelic Deletion Mutation of the DCAF17 Gene.

Frontiers in endocrinology
2022

Biallelic PROKR2 variants and congenital hypogonadotropic hypogonadism: a case report and a literature review.

Endocrine journal
2022

Compound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasis.

Orphanet journal of rare diseases
2022

Evaluation of Fundus Blood Flow Perfusion in Patients with Diabetic Retinopathy after PPV with Fundus Color Doppler Based on Big Data Mining.

Journal of healthcare engineering
2022

The presentation, course and outcome of COVID-19 infection in people with Prader-Willi syndrome: unexpected findings from an international survey.

Orphanet journal of rare diseases
2022

Approach to the Patient With Prader-Willi Syndrome.

The Journal of clinical endocrinology and metabolism
2021

Case Report: A Chinese Family of Woodhouse-Sakati Syndrome With Diabetes Mellitus, With a Novel Biallelic Deletion Mutation of the DCAF17 Gene.

Frontiers in endocrinology
2022

Novel splicing-site mutation in DCAF17 gene causing Woodhouse-Sakati syndrome in a large consanguineous family.

Journal of clinical laboratory analysis
2021

Woodhouse-Sakati syndrome (WSS): A case report of 3 Saudi sisters with urogenital anomalies.

Saudi medical journal
2021

Case Report: A Deletion Variant in the DCAF17 Gene Underlying Woodhouse-Sakati Syndrome in a Chinese Consanguineous Family.

Frontiers in genetics
2022

Expanding on the phenotypic spectrum of Woodhouse-Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review.

American journal of medical genetics. Part A
2021

Prevalence and incidence of physical health conditions in people with intellectual disability - a systematic review.

PloS one
2022

Writer's Cramp Presentation of Woodhouse-Sakati Syndrome - "Out of the Woods".

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2022

A rare canonical splice-site variant in VPS13B causes attenuated Cohen syndrome.

Ophthalmic genetics
2022

A Japanese patient with a 2p25.3 terminal deletion presented with early-onset obesity, intellectual disability and diabetes mellitus: A case report.

Journal of diabetes investigation
2021

Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome.

Journal of clinical medicine
2021

Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.

Biochemical pharmacology
2021

Differential DNA Methylation and Expression of miRNAs in Adipose Tissue From Twin Pairs Discordant for Type 2 Diabetes.

Diabetes
2021

HIST1H1E syndrome with type 2 diabetes.

BMJ case reports
2021

Bariatric and Metabolic Endoscopy: A New Paradigm.

Clinical and translational gastroenterology
2021

Quantitative Susceptibility Mapping in Woodhouse-Sakati Syndrome.

Annals of neurology
2021

Wolfram-like syndrome with bicuspid aortic valve due to a homozygous missense variant in CDK13.

Journal of human genetics
2021

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Annals of oncology : official journal of the European Society for Medical Oncology
2022

TRMT10A Mutation in a Child with Diabetes, Short Stature, Microcephaly and Hypoplastic Kidneys.

Journal of clinical research in pediatric endocrinology
2022

Multimodal Evoked Potential Profiles in Woodhouse-Sakati Syndrome.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2021

Fasting and fasting-mimicking diets for chemotherapy augmentation.

GeroScience
2021

Fulminant type 1 diabetes mellitus in a child with SMID leading to hypovolemic shock.

Pediatrics international : official journal of the Japan Pediatric Society
2020

Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology.

Bioscience reports
2020

COVID-19 Infection in a Patient With Fragile-X Syndrome.

Cureus
2021

SOX13 gene downregulation in peripheral blood mononuclear cells of patients with Klinefelter syndrome.

Asian journal of andrology
2020

tRNA methyltransferase 10 homologue A (TRMT10A) mutation in a Chinese patient with diabetes, insulin resistance, intellectual deficiency and microcephaly.

BMJ open diabetes research &amp; care
2020

Missed Diagnoses and Health Problems in Adults With Prader-Willi Syndrome: Recommendations for Screening and Treatment.

The Journal of clinical endocrinology and metabolism
2020

Biallelic TANGO1 mutations cause a novel syndromal disease due to hampered cellular collagen secretion.

eLife
2020

Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT.

BMC pediatrics
2020

Clinical Reasoning: Seven-year-old girl with progressive gait difficulties.

Neurology
2019

Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report.

Journal of medical case reports
2020

A novel autosomal recessive lipodystrophy syndrome due to homozygous LMNA variant.

Journal of medical genetics
2020

Obstructive Sleep Apnea in School-Aged Children Presented with Nocturnal Enuresis.

Lung
2019

Managing health changes for people with a learning disability in a residential care home setting.

International journal of palliative nursing
2020

Inborn errors of metabolism leading to neuronal migration defects.

Journal of inherited metabolic disease
2019

Patterns of neurological manifestations in Woodhouse-Sakati Syndrome.

Parkinsonism &amp; related disorders
2019

Computer Algorithms in Assessment of Obstructive Sleep Apnoea Syndrome and Its Application in Estimating Prevalence of Sleep Related Disorders in Population.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2019

A novel DCAF17 homozygous mutation in a girl with Woodhouse-Sakati syndrome and review of the current literature.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2020

Novel Intragenic PAX6 Deletion in a Pedigree with Aniridia, Morbid Obesity, and Diabetes.

Current eye research
2019

Woodhouse-Sakati Syndrome: First report of a Portuguese case.

American journal of medical genetics. Part A
2019

Phenotype evolution and health issues of adults with Beckwith-Wiedemann syndrome.

American journal of medical genetics. Part A
2020

Woodhouse-Sakati syndrome in a family is associated with a homozygous start loss mutation in the DCAF17 gene.

Clinical and experimental dermatology
2019

A case of Woodhouse-Sakati syndrome with pituitary iron deposition, cardiac and intestinal anomalies, with a novel mutation in DCAF17.

European journal of medical genetics
2020

Syndromic Disorders Caused by Disturbed Human Imprinting.

Journal of clinical research in pediatric endocrinology
2019

EED and EZH2 constitutive variants: A study to expand the Cohen-Gibson syndrome phenotype and contrast it with Weaver syndrome.

American journal of medical genetics. Part A
2019

Factors Associated with Alzheimer's Disease: An Overview of Reviews.

The journal of prevention of Alzheimer's disease
2019

Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5.

Journal of diabetes investigation
2019

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation
2018

Ciliopathy: Bardet-Biedl Syndrome.

Advances in experimental medicine and biology
2019

In vitro profiling of volatile organic compounds released by Simpson-Golabi-Behmel syndrome adipocytes.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2018

Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.

AJNR. American journal of neuroradiology
2018

A mosaic intragenic microduplication of LAMA1 and a constitutional 18p11.32 microduplication in a patient with keratosis pilaris and intellectual disability.

American journal of medical genetics. Part A
2018

Parental Burden and its Correlates in Families of Children with Autism Spectrum Disorder: A Multicentre Study with Two Comparison Groups.

Clinical practice and epidemiology in mental health : CP &amp; EMH
2018

Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome.

The American journal of case reports
2018

Neonatal hypoglycemia, early-onset diabetes and hypopituitarism due to the mutation in EIF2S3 gene causing MEHMO syndrome.

Physiological research
2018

High prevalence of diabetes mellitus, hypertension and obesity among persons with a recorded diagnosis of intellectual disability or autism spectrum disorder.

Journal of intellectual disability research : JIDR
2017

Diabetes Mellitus Secondary to Acute Pancreatitis in a Child with Wolf-Hirschhorn Syndrome.

Case reports in endocrinology
2017

'The obesity paradox': a reconsideration of obesity and the risk of preterm birth.

Journal of perinatology : official journal of the California Perinatal Association
2017

Early metabolic markers identify potential targets for the prevention of type 2 diabetes.

Diabetologia
2017

Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study.

Molecular genetics and metabolism
2017

Endocrine Autoimmunity in Down's Syndrome.

Frontiers of hormone research
2017

Obesity in adults with 22q11.2 deletion syndrome.

Genetics in medicine : official journal of the American College of Medical Genetics
2016

A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.

Arquivos de neuro-psiquiatria
2016

[GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION].

Ideggyogyaszati szemle
2016

Woodhouse-Sakati Syndrome: Report of the First Tunisian Family with the C2orf37 Gene Mutation.

Journal of movement disorders
2016

Genetics of human Bardet-Biedl syndrome, an updates.

Clinical genetics
2015

CANDLE Syndrome: orodfacial manifestations and dental implications.

Head &amp; face medicine
2015

The Use of High-Density SNP Array to Map Homozygosity in Consanguineous Families to Efficiently Identify Candidate Genes: Application to Woodhouse-Sakati Syndrome.

Case reports in genetics
2016

Exome sequencing revealed a novel biallelic deletion in the DCAF17 gene underlying Woodhouse Sakati syndrome.

Clinical genetics
2016

tRNA methyltransferase homologue gene TRMT10A mutation in young adult-onset diabetes with intellectual disability, microcephaly and epilepsy.

Diabetic medicine : a journal of the British Diabetic Association
2015

Novel compound heterozygous frameshift mutations of C2orf37 in a familial Indian case of Woodhouse-Sakati syndrome.

Journal of genetics
2015

Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome.

Human molecular genetics
2015

Homozygous deletion of TRMT10A as part of a contiguous gene deletion in a syndrome of failure to thrive, delayed puberty, intellectual disability and diabetes mellitus.

American journal of medical genetics. Part A
2015

A Missense Mutation in PPP1R15B Causes a Syndrome Including Diabetes, Short Stature, and Microcephaly.

Diabetes
2015

Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism.

PloS one
2015

Dammarane triterpenoids for pharmaceutical use: a patent review (2005 - 2014).

Expert opinion on therapeutic patents

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone.
    Investigative ophthalmology &amp; visual science· 2026· PMID 41660942mais citado
  2. Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.
    Lancet (London, England)· 2026· PMID 41520674mais citado
  3. Epidemiology, Comorbidities, and Healthcare Costs of Prader-Willi Syndrome in South Korea Using the Korean National Health Insurance Service Database.
    Journal of obesity &amp; metabolic syndrome· 2026· PMID 41871994mais citado
  4. Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.
    Cureus· 2026· PMID 41631087mais citado
  5. Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.
    Acta diabetologica· 2026· PMID 41591480mais citado
  6. [Clinical features and genetic analysis of a child with STISS syndrome due to variant of PSMD12 gene].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi· 2025· PMID 41811043recente
  7. A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes.
    J Pediatr Endocrinol Metab· 2025· PMID 40534546recente
  8. New Insights Into TRMT10A Syndrome: Case Report and Literature Review.
    Am J Med Genet B Neuropsychiatr Genet· 2025· PMID 39440920recente
  9. Recurrent carotid paragangliomas in a syndromic patient with a heterozygous missense variant in DNA Methyltransferase 3 Alpha.
    Am J Med Genet A· 2025· PMID 39166703recente
  10. Compound genetic etiology in a patient with a syndrome including diabetes, intellectual deficiency and distichiasis.
    Orphanet J Rare Dis· 2022· PMID 35227307recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:3044(Orphanet)
  2. OMIM OMIM:249599(OMIM)
  3. MONDO:0009581(MONDO)
  4. GARD:9811(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q55782074(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de perturbação do desenvolvimento intelectual-dismorfia-hipogonadismo-diabetes mellitus

ORPHA:3044 · MONDO:0009581
Prevalência
<1 / 1 000 000
Casos
4 casos conhecidos
Herança
Unknown
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1855303
Repurposing
40 candidatos
acarboseglucosidase inhibitor
acetohexamideATP channel blocker
alogliptindipeptidyl peptidase inhibitor
+17 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades